| ATV/r |  |  |  | LPV/r |  |  |  |
---|---|---|---|---|---|---|---|---|
As-Randomized | <50 | 50–<100 | 100–<200 | ≥200 | <50 | 50–<100 | 100–<200 | ≥200 |
ITT | n = 58 | n = 45 | n = 106 | n = 222 | n = 48 | n = 29 | n = 134 | n = 228 |
Responder | 45 (78) | 34 (76) | 80 (75) | 178 (80) | 30 (63) | 20 (69) | 104 (78) | 182 (80) |
Virologic failure* | 7 (12) | 7 (16) | 17 (16) | 26 (12) | 6 (13) | 7 (24) | 13 (10) | 24 (11) |
Discontinued | 6 (10) | 4 (9) | 9 (8) | 16 (7) | 12 (25) | 2 (7) | 16 (12) | 20 (9) |
On-treatment, n/N (%) | 45/52 (87) | 34/40 (85) | 80/95 (84) | 178/202 (88) | 30/35 (86) | 20/25 (80) | 104/114 (91) | 182/201 (91) |